Healthcare is quickly evolving into a digital-first operation, where top executives in the sector are doubling down on ...

In this Healio Video Perspective from the ARVO meeting, Paolo S. Silva, MD, discusses a study comparing ultrawide field ...

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 5, 2025 /PRNewswire/ --The ...

Jiarui Nie, a postdoctoral researcher at the National Institutes of Health, is exploring how gold nanoparticles injected into ...

Research and development expenses for the first quarter of 2025 were $42.9 million versus $20.7 million for the comparable ...

Postoperative endophthalmitis after cataract surgery is more than 17% more likely in patients with diabetes, while posterior ...

The therapy leverages the company’s intravitreal vector, R100, invented using the Therapeutic Vector Evolution platform.

Todd Engels, 62, from Maryland, started taking Ozempic after he saw glowing headlines and slick ads praising it as a 'miracle ...

LuxIA, an AI algorithm co-developed by RetinAI US and non-profit organisation Fundación Ver Salud (FVS), has achieved CE-MDR ...

ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the“Company”) recently announced U.S. FDA approval of its innovative yield enhancement production process. This innovative process has demonstrated an ...